What is DocGo's payments for repurchase of common stock?

DocGo (DCGO) reported payments for repurchase of common stock of $0 in Q1 2026.

How has DocGo's payments for repurchase of common stock changed year-over-year?

DocGo's payments for repurchase of common stock decreased by 100.0% year-over-year, from $5.75M to $0.

DocGo DCGO Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

Medline, Inc. MDLN

——

Other financials

Income statement

See full

Revenue$75.6M-21.3%

Gross profit-$407.9M-25.6%

Operating income-$18.7M-33.7%

Net income-$14.8M-57.0%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$46.8M-54.6%

Total debt$28.5M-7.6%

Total equity$132.3M-57.2%

Total assets$209.2M-51.4%

Cash flow

See full

Operating cash flow-$4.7M-151%

CapEx$430.3K-58.2%

Free cash flow-$5.1M-162%

Valuation

See full

Market cap$50.98M-67.2%

Enterprise value$32.67M-59.1%

P/S0.2×-0.2×

Profitability

See full

Operating margin-60.6%—

Net margin-62.2%—

FCF margin14.6%+8.1pp

Returns & leverage

See full

Return on equity-85%—

Debt / equity0.2×+0.1×

Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's payments for repurchase of common stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DocGo's payments for repurchase of common stock?: DocGo (DCGO) reported payments for repurchase of common stock of $0 in Q1 2026.
How has DocGo's payments for repurchase of common stock changed year-over-year?: DocGo's payments for repurchase of common stock decreased by 100.0% year-over-year, from $5.75M to $0.